These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24059399)

  • 1. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.
    Jeong HT; Kim MJ; Chung YE; Choi JY; Park YN; Kim KW
    AJR Am J Roentgenol; 2013 Oct; 201(4):W603-11. PubMed ID: 24059399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
    Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
    AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y; Lee JM; Kim SH; Han JK; Choi BI
    Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
    Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
    J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
    Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography.
    Kim JE; Lee JM; Kim SH; Baek JH; Moon SK; Yu IS; Kim SH; Lee JY; Han JK; Choi BI
    Radiology; 2010 Nov; 257(2):364-72. PubMed ID: 20829532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics.
    Choi JY; Kim MJ; Park YN; Lee JM; Yoo SK; Rha SY; Seok JY
    AJR Am J Roentgenol; 2011 Aug; 197(2):399-405. PubMed ID: 21785086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
    Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
    AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
    Kim SH; Lee CH; Kim BH; Kim WB; Yeom SK; Kim KA; Park CM
    J Comput Assist Tomogr; 2012; 36(6):704-9. PubMed ID: 23192208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
    Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
    J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
    Reiner CS; Merkle EM; Bashir MR; Walle NL; Nazeer HK; Gupta RT
    AJR Am J Roentgenol; 2013 Jul; 201(1):W49-56. PubMed ID: 23789696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
    Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
    Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.